Virtual Reality Based Cue-exposure Treatment for Bulimia Nervosa
Bulimia Nervosa, Binge-Eating Disorder, Binge Eating
About this trial
This is an interventional treatment trial for Bulimia Nervosa focused on measuring Bulimia nervosa, Binge eating disorder, Food craving, Anxiety, Bingeing, Cue Exposure Therapy, Virtual Reality
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of bulimia nervosa or binge eating disorder according the DSM-5
- Written and informed consent to participate
Exclusion Criteria:
- Other concurrent severe mental disorders (substance use disorders, bipolar disorder, psychosis)
- Suicidal ideation
Sites / Locations
- Università Cattolica del Sacro Cuore
- Universitat de Barcelona
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
VR based cue-exposure therapy
Additional Cognitive-behavioral treatment
Throughout the six sessions, participants (n=30) will be exposed to different VR environments related to binge behavior, according to a previously constructed hierarchy. During exposure, patients will face high risk situations to diminish or to extinguish the conditioned response of anxiety when exposed to food related cues. In each session, the patient will be exposed to the corresponding step of the hierarchy. During the exposure session, the patient can handle the virtual foods using the laptop's mouse but cannot eat the foods (exposure with response prevention). Exposure will end when the anxiety level decreased by 40% in relation to the level registered at the initiation of the exposure session or after 60 minutes of exposure.
Participants (n=30) in this condition will receive six CBT booster sessions (two sessions per week) over the course of three weeks to improve the output of treatment. CBT sessions are based on the approach described by by Eldredge and colleagues (Eldredge et al.,1997). In this treatment program, patients are trained to self-monitor their food patterns and to identify and manage thoughts, emotions, and environmental factors related to disrupted eating behaviors.